Clearstead Trust’s QuidelOrtho QDEL Stock Holding History

Clearstead Trust’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-49	Closed	-$1.44K	–	1415
2025 Q3	$1.44K	Hold	49	–	–	﹤0.01%	1101
2025 Q2	$1.41K	Buy	+49	New	+$1.45K	﹤0.01%	1050

Other funds holding QDEL

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Clearstead Trust's QDEL Position: Q4 2025 in Review

Clearstead Trust sold out of QuidelOrtho (QDEL) in Q4 2025, closing a stake of 49 shares — an estimated $1.44K sold.

Clearstead Trust first reported a position in QDEL in Q2 2025 and held it in 2 quarters. The position peaked at $1.44K in Q3 2025. 244 funds tracked by Wall St. Rank hold QDEL as of Q4 2025.

Clearstead Trust reported no remaining QuidelOrtho position as of Q4 2025 after selling out during the quarter.
Clearstead Trust sold 49 QuidelOrtho shares in Q4 2025, an estimated $1.44K.
Clearstead Trust first reported a position in QuidelOrtho in Q2 2025 and held it in 2 quarters.
Clearstead Trust's QuidelOrtho position peaked at $1.44K in Q3 2025.
244 funds tracked by Wall St. Rank held QuidelOrtho as of Q4 2025.

Based on Clearstead Trust's 13F filing for Q4 2025, filed 9 Feb 2026.